Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.

Source:http://linkedlifedata.com/resource/pubmed/id/12850791

Download in:

View as

General Info

PMID
12850791